MS

Meenakshi Seshagiri Gad

Director Director DIN 06804227
DIN 06804227 First appointment Jan 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Meenakshi Seshagiri Gad

Data last updated:

Meenakshi Seshagiri Gad was a Director at Goa Antibiotics And Pharmaceuticals Limited (2014) and Director at Edc Limited (2015–2017). The companies operate in Pharma and Financial Services.

DIN 06804227
Primary Designation Director
Industry Pharma
First Appointment 22 Jan 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jan 20141980₹29.84 Cr (FY 2025)Active
Edc Limited U65993GA1975SGC000214
Director26 Mar 20151975₹101 Cr (FY 2019)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Goa Antibiotics And Pharmaceuticals Limited
Edc Limited
Premium access

Shareholding and investment profile for Meenakshi Seshagiri Gad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenakshi Seshagiri Gad

Meenakshi Seshagiri Gad was first appointed on 22 Jan 2014 as Director at Goa Antibiotics And Pharmaceuticals Limited. The most recent appointment on record is 26 Mar 2015 at Edc Limited.

Meenakshi Seshagiri Gad held 2 earlier board appointments: Goa Antibiotics And Pharmaceuticals Limited (Director, 22 Jan 2014 to 19 Mar 2014); Edc Limited (Director, 26 Mar 2015 to 07 Apr 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available